(Q43863012)

English

Clinical trials in spinal cord injury: lessons learned on the path to translation. The 2011 International Spinal Cord Society Sir Ludwig Guttmann Lecture

scientific article published on 20 November 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Clinical trials in spinal cord injury: lessons learned on the path to translation. The 2011 International Spinal Cord Society Sir Ludwig Guttmann Lecture (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

lessons learned

1 reference

based on heuristic

inferred from title

author name string

D P Lammertse

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

20 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2-9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Review of treatment trials in human spinal cord injury: issues, difficulties, and recommendations

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Emerging repair, regeneration, and translational research advances for spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Recommendations for advancing development of acute stroke therapies: Stroke Therapy Academic Industry Roundtable 3.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Steroids and spinal cord injury: revisiting the NASCIS 2 and NASCIS 3 trials

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Pharmacological Therapy after Acute Cervical Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Neuroprotection and acute spinal cord injury: a reappraisal

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

The two-edged sword of large-dose steroids for spinal cord trauma

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Consequences of high-dose steroid therapy for acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Early complications of high-dose methylprednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

High-dose methylprednisolone may cause myopathy in acute spinal cord injury patients

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Traumatic thoracic ASIA A examinations and potential for clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Extent of spontaneous motor recovery after traumatic cervical sensorimotor complete spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Phase 2 trial of sustained-release fampridine in chronic spinal cord injury.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

A phase 2 autologous cellular therapy trial in patients with acute, complete spinal cord injury: pragmatics, recruitment, and demographics

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Autologous incubated macrophage therapy in acute, complete spinal cord injury: results of the phase 2 randomized controlled multicenter trial.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Laufband locomotion with body weight support improved walking in persons with severe spinal cord injuries

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Weight-supported treadmill vs over-ground training for walking after acute incomplete SCI.

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Should body weight-supported treadmill training and robotic-assistive steppers for locomotor training trot back to the starting gate?

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

The translational dialogue in spinal cord injury research

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

What matters in cellular transplantation for spinal cord injury: the cells, the rehabilitation, or the best mix?

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Position statement on the sale of unproven cellular therapies for spinal cord injury The International Campaign for Cures of Spinal Cord Injury Paralysis

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

21 January 2018

Efficacy of Methylprednisolone in Acute Spinal Cord Injury

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological therapy of spinal cord injury during the acute phase

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

Methylprednisolone after traumatic spinal cord injury: yes or no?

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

The Sygen multicenter acute spinal cord injury study

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

Treadmill training after spinal cord injury: good but not better

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

Treadmill training after spinal cord injury: good but not better

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

Treadmill training after spinal cord injury: good but not better

1 reference

https://api.crossref.org/works/10.1038%2FSC.2012.137

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SC.2012.137

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43863012&oldid=2206301311"